101 related articles for article (PubMed ID: 8356310)
1. [Insulin resistance: related clinical syndromes].
Cangemi C; Lombardo G; Sinagra D
Recenti Prog Med; 1993; 84(7-8):541-50. PubMed ID: 8356310
[TBL] [Abstract][Full Text] [Related]
2. [Early metabolic abnormalities--insulin resistance, hyperinsulinemia, impaired glucose tolerance and diabetes, in adolescent girls with polycystic ovarian syndrome].
Otto-Buczkowska E; Jarosz-Chobot P; Deja G
Przegl Lek; 2006; 63(4):234-8. PubMed ID: 17080748
[TBL] [Abstract][Full Text] [Related]
3. [Insulin resistance: from clinical diagnosis to molecular genetics. Implications in diabetes mellitus].
Jaffiol C; Rouard M; Macari F; Lautier C; Ait el Mkadem S; Méchaly I; Brun JF; Renard E; Cros G; Bringer J; Grigorescu F
Bull Acad Natl Med; 1999; 183(9):1761-75; discussion 1775-7. PubMed ID: 10987057
[TBL] [Abstract][Full Text] [Related]
4. [Hypertension and insulin resistance].
Voiculescu A; Kutkuhn B; Rösen P; Grabensee B
Wien Klin Wochenschr; 1997 Oct; 109(19):758-66. PubMed ID: 9441522
[TBL] [Abstract][Full Text] [Related]
5. Plasma cell membrane glycoprotein 1 (PC-1): a marker of insulin resistance in obesity, uremia and diabetes mellitus.
Stefanović V; Antić S
Clin Lab; 2004; 50(5-6):271-8. PubMed ID: 15209435
[TBL] [Abstract][Full Text] [Related]
6. [Amylin as an additional possible pathogenic factor in NIDDM and the insulin resistance syndrome].
Hrnciar J
Vnitr Lek; 1996 Aug; 42(8):557-60. PubMed ID: 8967027
[TBL] [Abstract][Full Text] [Related]
7. The obesity syndrome and acanthosis nigricans. Acanthosis nigricans is a common cosmetic problem providing epidemiological clues to the obesity syndrome, the insulin-resistance syndrome, the thrifty metabolism, dyslipidaemia, hypertension and diabetes mellitus type II.
Maitra SK; Rowland Payne CM
J Cosmet Dermatol; 2004 Dec; 3(4):202-10. PubMed ID: 17166107
[TBL] [Abstract][Full Text] [Related]
8. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
9. The origins and consequences of obesity. Diabetes.
Björntorp P
Ciba Found Symp; 1996; 201():68-80; discussion 80-9, 188-93. PubMed ID: 9017275
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of insulin resistance and associated diseases.
Mlinar B; Marc J; Janez A; Pfeifer M
Clin Chim Acta; 2007 Jan; 375(1-2):20-35. PubMed ID: 16956601
[TBL] [Abstract][Full Text] [Related]
11. Treatment options in insulin resistance obesity-related acanthosis nigricans.
Romo A; Benavides S
Ann Pharmacother; 2008 Jul; 42(7):1090-4. PubMed ID: 18492785
[TBL] [Abstract][Full Text] [Related]
12. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
[TBL] [Abstract][Full Text] [Related]
13. Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease.
Caballero AE
Obes Res; 2003 Nov; 11(11):1278-89. PubMed ID: 14627747
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance and obesity.
Greenfield JR; Campbell LV
Clin Dermatol; 2004; 22(4):289-95. PubMed ID: 15475228
[TBL] [Abstract][Full Text] [Related]
15. Acanthosis Nigricans, insulin resistance (HOMA) and dyslipidemia among Native American children.
Copeland K; Pankratz K; Cathey V; Immohotichey P; Maddox J; Felton B; McIntosh R; Parker D; Burgin C; Blackett P
J Okla State Med Assoc; 2006 Jan; 99(1):19-24. PubMed ID: 16499154
[TBL] [Abstract][Full Text] [Related]
16. Induction of ovulation in infertile women with hyperandrogenism and insulin resistance.
Barbieri RL
Am J Obstet Gynecol; 2000 Dec; 183(6):1412-8. PubMed ID: 11120504
[TBL] [Abstract][Full Text] [Related]
17. [Correlation between menstruation disorders and insulin resistance].
González Centeno A; Nahum Hernández P; Mendoza R; Ayala AR
Ginecol Obstet Mex; 2003 Jun; 71():312-7. PubMed ID: 14515662
[TBL] [Abstract][Full Text] [Related]
18. [Receptor dysfunction as a pathogenetic principle in hormone resistance and metabolic diseases].
Tenschert W; Vetter H; Siegenthaler W; Vetter W
Schweiz Med Wochenschr; 1981 Feb; 111(6):174-81. PubMed ID: 6261324
[TBL] [Abstract][Full Text] [Related]
19. Case problem: dietary recommendations to combat obesity, insulin resistance, and other concerns related to polycystic ovary syndrome.
J Am Diet Assoc; 2000 Aug; 100(8):955-7; discussion 957-60. PubMed ID: 10955058
[No Abstract] [Full Text] [Related]
20. Polycystic ovary syndrome and type 2 diabetes mellitus.
De Leo V; Musacchio MC; Morgante G; La Marca A; Petraglia F
Minerva Ginecol; 2004 Feb; 56(1):53-62. PubMed ID: 14973410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
